Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (211-220 of 386) with videos related to

Pageof 39
Sort By:
Hepatology (Baltimore, Md.)|September 24, 2004
Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytesYouwen Fang, Song Iy Han, Clint Mitchell, et al.
Molecular and Cellular Biology|June 6, 2007
The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stressMohamed Rahmani, Eric Maynard Davis, Timothy Ryan Crabtree, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2011
HDAC inhibitors potentiate the activity of the BCR/ABL kinase inhibitor KW-2449 in imatinib-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivoTri Nguyen, Yun Dai, Elisa Attkisson, et al.
Clinical Lymphoma & Myeloma|September 1, 2009
Mantle cell lymphoma: biological insights and treatment advancesJohn P Leonard, Michael E Williams, Andre Goy, et al.
European Journal of Medicinal Chemistry|November 15, 2011
3,5-Disubstituted-thiazolidine-2,4-dione analogs as anticancer agents: design, synthesis and biological characterizationKai Liu, Wei Rao, Hardik Parikh, et al.
Oncotarget|September 17, 2019
Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur <i>in vitro</i> and <i>in vivo</i> and proceed through multiple mechanismsTri Nguyen, Rebecca Parker, Elisa Hawkins, et al.
Blood|October 21, 2004
Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNKYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Cancer Biology & Therapy|August 19, 2008
Searching for a cure: gene therapy for glioblastomaPaul Dent, Adly Yacoub, Margaret Park, et al.
Molecular Cancer Therapeutics|June 5, 2019
Retraction: Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells <i>In Vitro</i> and <i>In Vivo</i>Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Molecular Cancer Therapeutics|November 9, 2005
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cellsRoberto R Rosato, Jorge A Almenara, Sonia C Maggio, et al.
Pageof 39

Showing results (211-220 of 386) with videos related to

Sort By:
Pageof 39
Hepatology (Baltimore, Md.)|September 24, 2004
Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytesYouwen Fang, Song Iy Han, Clint Mitchell, et al.
Molecular and Cellular Biology|June 6, 2007
The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stressMohamed Rahmani, Eric Maynard Davis, Timothy Ryan Crabtree, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2011
HDAC inhibitors potentiate the activity of the BCR/ABL kinase inhibitor KW-2449 in imatinib-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivoTri Nguyen, Yun Dai, Elisa Attkisson, et al.
Clinical Lymphoma & Myeloma|September 1, 2009
Mantle cell lymphoma: biological insights and treatment advancesJohn P Leonard, Michael E Williams, Andre Goy, et al.
European Journal of Medicinal Chemistry|November 15, 2011
3,5-Disubstituted-thiazolidine-2,4-dione analogs as anticancer agents: design, synthesis and biological characterizationKai Liu, Wei Rao, Hardik Parikh, et al.
Oncotarget|September 17, 2019
Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur <i>in vitro</i> and <i>in vivo</i> and proceed through multiple mechanismsTri Nguyen, Rebecca Parker, Elisa Hawkins, et al.
Blood|October 21, 2004
Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNKYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Cancer Biology & Therapy|August 19, 2008
Searching for a cure: gene therapy for glioblastomaPaul Dent, Adly Yacoub, Margaret Park, et al.
Molecular Cancer Therapeutics|June 5, 2019
Retraction: Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells <i>In Vitro</i> and <i>In Vivo</i>Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Molecular Cancer Therapeutics|November 9, 2005
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cellsRoberto R Rosato, Jorge A Almenara, Sonia C Maggio, et al.
Pageof 39